FREELINE THERAPEUTICS HLDGS
SPONSORED ADS · CUSIP 35655L107
1
institutional holders
-15 vs Q1 2023
1.5m
shares reported held*
$3.8mreported value*
0 new
0 added
1 reduced
14 sold out
net sold ≈ $91.2m (-35.4m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.58.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 15 |
| Q4 2022 | 17 |
| Q1 2023 | 16 |
| Q2 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 5 |
| Q1 2023 | 4 | 8 |
| Q2 2023 | 0 | 15 |
Biggest buyers
| None |
Biggest sellers
| Syncona Portfolio Ltd | Reduced | -20.5m |
| CHI Advisors LLC | Sold out | -4.7m |
| EVENTIDE ASSET MANAGEMENT, LLC | Sold out | -4.7m |
| Tetragon Partners GP Ltd | Sold out | -4.0m |
| UBS Group AG | Sold out | -500.0k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -230.6k |
| MORGAN STANLEY | Sold out | -189.5k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -162.2k |
| CITADEL ADVISORS LLC | Sold out | -116.8k |
| HARBOR CAPITAL ADVISORS, INC. | Sold out | -107.7k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Syncona Portfolio Ltd 5.70% of their portfolio | 1.5m $3.8m | Reduced -20.5m |